About us   Projects   Partnership
line   line   line



Teligene is a drug discovery company engaged in developing targeted small molecule drug therapeutics for the treatment of cancer. We utilize highly effective structural approaches to drug design and optimization.

Our goal is to deliver better outcomes for patients living with cancer.


HERS inhibitor


Partnership built on a foundation of aligned interests and mutual respect is essential.

We maximize the value of the molecules we discover by putting them in the hands of quality partners.


ALK inhibitor


BRAF inhibitor

  tag4 HDAC inhibitor  
read more
read more
read more


copyright 2012 Teligene